News tagged with marrow toxicity
Phase I trial begins using gene therapy and bone marrow stem cells in the treatment of brain cancer
University Hospitals (UH) Case Medical Center, Case Western Reserve University School of Medicine and Lentigen Corporation announced today the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection ...
Nov 14, 2011 |
5 / 5 (1) |
0
Drug mitigates toxic effects of radiation in mice
While radiation has therapeutic uses, too much radiation is damaging to cells. The most important acute side effect of radiation poisoning is damage to the bone marrow. The bone marrow produces all the normal blood cells, ...
Medicine & Health / Medications
Jun 23, 2010 |
5 / 5 (1) |
0
Search results for marrow toxicity
Complications of blood cancers make termination advisable at early stages of pregnancy
Lymphoma is the fourth most common cancer in pregnancy, affecting one in 6000 pregnancies. Non-Hodgkin lymphoma, acute leukaemia, and other blood cancers, while also rare, can also occur in pregnancy. The need for urgent ...
Feb 09, 2012 |
not rated yet |
0
Towards more effective treatment for multiple myeloma
A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, ...
Jan 09, 2012 |
5 / 5 (2) |
0
|
Researchers successfully treat previously lethal doses of radiation
Multiple scenarios exist where warfighters may be exposed to high levels of radiation. Countermeasures against possible high doses of radiation are an ongoing high priority for Department of Defense research ...
Jan 05, 2012 |
5 / 5 (4) |
0
Spread of nasopharyngeal carcinoma is reduced by bevacizumab, according to phase 2 trial results
The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects.
Dec 16, 2011 |
not rated yet |
0
AML patients have high response rate with vorinostat added to treatment
Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center ...
Dec 13, 2011 |
not rated yet |
0
HIV drug reduces graft-versus-host disease in stem cell transplant patients
An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease (GvHD) in blood cancer patients following allogeneic stem cell transplantation (ASCT), according ...
Dec 13, 2011 |
not rated yet |
1
B cell receptor inhibitor causes chronic lymphocytic leukemia remission
A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting ...
Dec 11, 2011 |
5 / 5 (2) |
0
Study identifies possible therapy for radiation sickness
A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists ...
Nov 23, 2011 |
4.8 / 5 (6) |
3
|
Age no longer a barrier to stem cell transplantation for older patients
Age alone no longer should be considered a defining factor when determining whether an older patient with blood cancer is a candidate for stem cell transplantation. That's the conclusion of the first study summarizing long-term ...
Nov 01, 2011 |
4 / 5 (1) |
0
|
Scientists look to immune system to handle follicular lymphoma
University of Rochester Medical Center researchers found more evidence that T cells going awry in the microenvironment – or the tissue immediately surrounding the tumor – may play a role in the biology ...
Oct 12, 2011 |
5 / 5 (3) |
0
|
List of search results for marrow toxicity
